Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Increases By 41.7%

Lexaria Bioscience Corp. (NASDAQ:LEXXWGet Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 5,100 shares, an increase of 41.7% from the September 30th total of 3,600 shares. Based on an average daily trading volume, of 14,200 shares, the days-to-cover ratio is presently 0.4 days.

Lexaria Bioscience Stock Down 3.4 %

Shares of Lexaria Bioscience stock traded down $0.03 during trading on Tuesday, reaching $0.85. 300 shares of the company traded hands, compared to its average volume of 15,426. The company has a 50 day moving average price of $0.99 and a 200-day moving average price of $1.10. Lexaria Bioscience has a 1-year low of $0.12 and a 1-year high of $2.50.

About Lexaria Bioscience

(Get Free Report)

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.

See Also

Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.